LEADER 01340oam  2200373z- 450 
001 9910689861303321
005 20230509155608.0
035   $a(CKB)5470000000935215
035   $a(WsH)cbhfdsohenkcn
035   $a(BIP)012480526
035   $a(EXLCZ)995470000000935215
100   $a20211006c2005uuuu  -u-         -
101 0 $aeng
200 10$aHuman subjects protections in VA research $ehearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, House of Representatives, One Hundred Eighth Congress, first session, June 18, 2003
215   $a1 online resource (iii, 89 p.) 
311   $a0-16-074338-9 
517   $aH.R. 1720, H.R. 116, H.R. 2307, and H.R. 2349
606   $aHuman experimentation in medicine$zUnited States$xEvaluation
606   $aEvaluation Studies as Topic
606   $aHuman Experimentation
606   $aVeterans
607   $aUnited States
610   $aHuman experimentation in medicine
610   $aVeterans
610   $aMedical
610   $aHistory
615  0$aHuman experimentation in medicine$xEvaluation.
615  2$aEvaluation Studies as Topic.
615  2$aHuman Experimentation.
615  2$aVeterans.
906   $aBOOK
912   $a9910689861303321
996   $aHuman subjects protections in VA research$93140495
997   $aUNINA